The role of Numb as a tumor suppressor in breast cancer has been proposed by several studies that reported that the removal of Numb resulted in reduced TP53 levels and impaired TP53, apoptosis and DNA-damage checkpoint activation. Here, TP53 is linked to breast cancer.